Associations, overlaps and dissociations between apathy and fatigue.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 05 2022
Historique:
received: 14 12 2021
accepted: 01 04 2022
entrez: 5 5 2022
pubmed: 6 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Apathy and fatigue have a high prevalence in many pathological populations, but they are also present in healthy adults. The relationship between apathy and fatigue, which are both multidimensional, is still poorly understood. This study aims to describe the associations between the subdimensions of both apathy and fatigue and to investigate their overlaps and dissociations in healthy people. 729 participants (mean age = 30.8 ± 10.7 years) completed online self-assessment questionnaires. The Apathy Motivation Index and Dimensional Apathy Scale were used to assess apathy. The Multidimensional Fatigue Inventory was used to assess fatigue. The executive dimension of apathy showed the strongest correlations with mental fatigue and the two appeared to be underpinned by the same latent factor, according to exploratory factor analysis (EFA). The factor structure of EFA showed overlaps between behavioral apathy and both reduced motivation and activity in fatigue. Emotional and social dimensions of apathy were separately underpinned by a latent factor that comprised no items of fatigue. Apathy and fatigue have reduced activity and mental difficulties in common, whereas emotional and social disorders distinguish apathy from fatigue. This has important implications for assessing apathy and fatigue in the general population, and may be relevant for clinical practice.

Identifiants

pubmed: 35513461
doi: 10.1038/s41598-022-11071-5
pii: 10.1038/s41598-022-11071-5
pmc: PMC9072543
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7387

Informations de copyright

© 2022. The Author(s).

Références

Behav Neurosci. 2013 Apr;127(2):237-44
pubmed: 23339489
Neurology. 2013 Jan 22;80(4):409-16
pubmed: 23339207
PLoS One. 2017 Jan 11;12(1):e0169938
pubmed: 28076387
Brain. 2017 Aug 1;140(8):2240-2245
pubmed: 28899013
Acta Neurol Scand. 2015 Feb;131(2):80-7
pubmed: 25288130
Alzheimers Dement. 2021 Dec;17(12):1892-1904
pubmed: 33949763
Front Neurol. 2021 Aug 26;12:720921
pubmed: 34512530
J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):887-95
pubmed: 20418349
Br J Soc Psychol. 2005 Jun;44(Pt 2):268-87
pubmed: 16004649
Neuropsychologia. 2018 Sep;118(Pt B):54-67
pubmed: 28689673
J Psychosom Res. 1995 Apr;39(3):315-25
pubmed: 7636775
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):302-312
pubmed: 30366958
Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):585-97
pubmed: 22921248
Eur J Cancer Care (Engl). 2003 Mar;12(1):58-64
pubmed: 12641557
Sci Rep. 2016 Feb 19;6:21386
pubmed: 26893077
Behav Neurosci. 2010 Jun;124(3):329-36
pubmed: 20528076
Cortex. 2020 Jul;128:326-327
pubmed: 32370877
J Neurol Sci. 2000 Oct 1;179(S 1-2):34-42
pubmed: 11054483
Mov Disord. 2018 Nov;33(11):1712-1723
pubmed: 30264539
J Physiol Paris. 2015 Feb-Jun;109(1-3):16-26
pubmed: 24747776
Parkinsonism Relat Disord. 2009 May;15(4):295-9
pubmed: 18801696
J Neurol. 2013 Oct;260(10):2481-90
pubmed: 23793818
Sci Rep. 2021 Nov 15;11(1):22283
pubmed: 34782630
Cortex. 2018 Jun;103:350-359
pubmed: 29704671
Psychiatry Res. 2014 Nov 30;219(3):658-63
pubmed: 24972546
Front Pharmacol. 2020 Jan 23;10:1581
pubmed: 32038253
Eur Psychiatry. 2018 Oct;54:71-76
pubmed: 30125783
West J Nurs Res. 2003 Jun;25(4):419-33
pubmed: 12790057
Nat Commun. 2020 Aug 12;11(1):4026
pubmed: 32788604
Expert Rev Neurother. 2020 May;20(5):477-495
pubmed: 32290717
Nat Hum Behav. 2017 Jul;1(7):0131
pubmed: 28819649
Neuropsychologia. 2019 Feb 4;123:141-151
pubmed: 29738794
J Neurosci. 2014 Nov 19;34(47):15621-30
pubmed: 25411490

Auteurs

Lyne Daumas (L)

Université Côte d'Azur, CoBTeK Lab, Nice, France. daumas.l@chu-nice.fr.
Université Côte d'Azur, LAMHESS Lab, Nice, France. daumas.l@chu-nice.fr.

Camille Corbel (C)

Université Côte d'Azur, CoBTeK Lab, Nice, France.
Université Côte d'Azur, LAPCOS Lab, Nice, France.

Raphaël Zory (R)

Université Côte d'Azur, LAMHESS Lab, Nice, France.
Institut Universitaire de France, Paris, France.

Xavier Corveleyn (X)

Université Côte d'Azur, LAPCOS Lab, Nice, France.

Roxane Fabre (R)

Université Côte d'Azur, CoBTeK Lab, Nice, France.
Public Health Department, Université Côte d'Azur, Nice University Hospital, Nice, France.

Philippe Robert (P)

Université Côte d'Azur, CoBTeK Lab, Nice, France.

Valeria Manera (V)

Université Côte d'Azur, CoBTeK Lab, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH